Brochure | June 3, 2020

Fill Finish Capabilities: COVID-19

Bringing Covid-19 therapeutic solutions to the clinic and market with speed, precision and scalability is now a challenge with unparalleled consequence. Ajinomoto Bio-Pharma Services remains committed to helping customers address the global demand for a solution.

Utilize our state-of-the-art manufacturing facilities, technical expertise and innovative GMP compliant processes to support a broad range of molecule types:

  • Vaccines
  • Adjuvants
  • Monoclonal Antibodies
  • Peptides
  • Oligonucleotides
  • Recombinant Proteins
  • Recombinant DNA
  • Plasmid DNA
  • Suspensions
  • Small Molecules

See an overview of the Analytical, Regulatory, and Formulation Services - along with the Vial and Syringe filling capabilities as we respond to the COVID-19 pandemic.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma

Ajinomoto Bio-Pharma Services